What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Myocardial infarction
Robert-Jan van Geuns mainly investigates Internal medicine, Cardiology, Radiology, Coronary artery disease and Myocardial infarction.
His research on Internal medicine often connects related areas such as Surgery.
His Cardiology research incorporates elements of Confidence interval, Hazard ratio and Clinical endpoint.
His Radiology research includes themes of Electrocardiography, Coronary arteries and Everolimus.
His Coronary artery disease research is multidisciplinary, relying on both Conventional PCI, Acute coronary syndrome, Intravascular ultrasound, Fractional flow reserve and Angiography.
His Myocardial infarction research focuses on subjects like Restenosis, which are linked to Thrombosis, Lumen and Target lesion.
His most cited work include:
- Images in Cardiovascular Medicine (1519 citations)
- Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial (567 citations)
- Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents (544 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Cardiology, Percutaneous coronary intervention, Coronary artery disease and Radiology.
His Internal medicine study frequently draws connections between related disciplines such as Surgery.
His work carried out in the field of Cardiology brings together such families of science as Magnetic resonance imaging and Hazard ratio.
As a part of the same scientific study, Robert-Jan van Geuns usually deals with the Percutaneous coronary intervention, concentrating on Conventional PCI and frequently concerns with Confidence interval.
His research integrates issues of Lesion, Cardiovascular agent, Revascularization, Thrombosis and Prospective cohort study in his study of Coronary artery disease.
His Radiology study incorporates themes from Coronary angiography, Coronary arteries and Nuclear medicine.
He most often published in these fields:
- Internal medicine (56.03%)
- Cardiology (50.22%)
- Percutaneous coronary intervention (29.69%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (56.03%)
- Cardiology (50.22%)
- Percutaneous coronary intervention (29.69%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Cardiology, Percutaneous coronary intervention, Coronary artery disease and Conventional PCI.
Myocardial infarction, Clinical endpoint, Acute coronary syndrome, Hazard ratio and Intravascular ultrasound are the core of his Internal medicine study.
His biological study spans a wide range of topics, including Prospective cohort study and Magnetic resonance imaging.
The study incorporates disciplines such as Stroke, Stent and Coronary stent in addition to Percutaneous coronary intervention.
His Stent research is included under the broader classification of Surgery.
His research in Coronary artery disease intersects with topics in Lesion, Culprit, Coronary arteries, Radiology and Thrombosis.
Between 2016 and 2021, his most popular works were:
- Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial (259 citations)
- Integrating CT Myocardial Perfusion and CT-FFR in the Work-Up of Coronary Artery Disease. (73 citations)
- Multiple Common Comorbidities Produce Left Ventricular Diastolic Dysfunction Associated With Coronary Microvascular Dysfunction, Oxidative Stress, and Myocardial Stiffening (72 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Myocardial infarction
His main research concerns Internal medicine, Cardiology, Coronary artery disease, Percutaneous coronary intervention and Conventional PCI.
All of his Internal medicine and Myocardial infarction, Intravascular ultrasound, Prospective cohort study, Revascularization and Predictive value of tests investigations are sub-components of the entire Internal medicine study.
His Cardiology research includes elements of Clinical endpoint and Hazard ratio.
Robert-Jan van Geuns has researched Coronary artery disease in several fields, including Fractional flow reserve, Radiology, Acute coronary syndrome and Mace.
The various areas that he examines in his Percutaneous coronary intervention study include Survival analysis, Conditional survival and Cumulative survival.
His study in Conventional PCI is interdisciplinary in nature, drawing from both Hemodynamics, Percutaneous, Randomized controlled trial and Confidence interval.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
